Cimicifuga Atractylodes Decoction Clinical Observation Of Ankylosing Spondylitis

Objective: Treatment of Cimicifuga Atractylodes ankylosing spondylitis (AS) alpine closed block the efficacy and safety certificates.Methods:A randomized, controlled method,60 patients with AS alpine closure retention syndrome were randomly divided into groups and Western medicine Group, the Medicines Cimicifuga Atractylodes Decoction to western medicine group given sulfasalazine (SASP) therapy, continuous administration 6 Months International ASAS working group developed by the ASAS20, BASDAI50 standards and standards of TCM syndromes, assessment AS the efficacy of traditional Chinese medicine pricesResults:The patients disease activity index of Bath, Bath functional index, pain, inflammation, clinical disease index Status were significantly improved, ESR, CRP has also improved; treatment group significantly improved clinical symptoms of traditional Chinese medicine. Higher than the efficacy of the treatment group, adverse reactions.Conclusion:Treatment of Cimicifuga AS Baizhu clinical satisfaction, and its mechanism may be related to anti-inflammatory, analgesic, improving Blood flow change, enhance immunity, inhibit osteoclast and other relevant, security, and compliance is good, there is broad application prospects...